1. Jim Cramer Profile - CNBC

    https://www.cnbc.com/jim-cramer/

    Host of "Mad Money w/ Jim Cramer" & Co-Anchor CNBC’s "Squawk on the Street" Jim Cramer believes there is always a bull market somewhere, and he wants to help you find it.

  2. Jim Cramer says ‘run with the bulls’ and buy these winning ...

    https://www.cnbc.com/2021/08/25/jim-cramer-says-run-with-the-bulls-and-buy-these-winning-stocks.html

    CNBC's Jim Cramer offered investors a basket of stocks he believes can continue to succeed irrespective of Federal Reserve policy. Among the companies are Nvidia, Best Buy and Deere.

  3. Jim Cramer - Wikipedia

    https://en.wikipedia.org/wiki/Jim_Cramer

    CNBC. Cramer was a frequent guest commentator on CNBC in the late 1990s. From 2002 to 2005, Cramer co-hosted Kudlow & Cramer (first called America Now) with Larry Kudlow. Mad Money with Jim Cramer first aired on CNBC in 2005.

  4. Jim Cramer says the turnaround of Best Buy proves Amazon's ...

    https://www.cnbc.com/2021/08/24/jim-cramer-says-the-turnaround-of-best-buy-proves-amazons-death-star-days-are-over.html

    CNBC's Jim Cramer said Tuesday he no longer views ecommerce behemoth Amazon as a so-called "death star." I still like the company and the stock, but it's no longer laying waste to the entire ...

  5. CNBC’s Jim Cramer: ‘I Own Ethereum Directly’ – Coin Graph ...

    https://coingraph.uno/2021/08/27/cnbcs-jim-cramer-i-own-ethereum-directly/

    Cramer is the host of CNBC show “ Mad Money w/ Jim Cramer “. He is also a co-anchor of CNBC’s “ Squawk on the Street “, as well as a co-founder of financial news website TheStreet. Here’s how Cramer got into crypto. On 10 September 2020, Anthony Pompliano (aka “Pomp”), who is a co-founder of Morgan Creek Digital as well as the ...

  6. Jim Cramer says the rally in drug stocks is 'far from over'

    https://www.cnbc.com/2021/08/18/jim-cramer-says-the-rally-in-drug-stocks-is-far-from-over.html

    CNBC's Jim Cramer said Wednesday the recent "stealth move" higher in drugmaker stocks can last a bit longer, believing the broad cohort is benefiting from a lack of Washington scrutiny.